Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.285 USD | -0.35% | +14.00% | -86.10% |
Apr. 15 | Ampio Pharmaceuticals, Inc.(NYSEAM:AMPE) dropped from S&P TMI Index | CI |
Mar. 27 | Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 6
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Martino
CEO | Chief Executive Officer | 68 | 21-10-12 |
Howard Levy
CTO | Chief Tech/Sci/R&D Officer | 70 | 21-10-12 |
Laura Goldberg
LAW | General Counsel | - | 13-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Stevens
BRD | Director/Board Member | 75 | 11-05-31 |
J. Buchi
CHM | Chairman | 69 | 21-10-12 |
Michael Martino
CEO | Chief Executive Officer | 68 | 21-10-12 |
Elizabeth Jobes
BRD | Director/Board Member | 57 | 22-02-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,135,358 | 1,117,631 ( 98.44 %) | 0 | 98.44 % |
Company contact information
Ampio Pharmaceuticals, Inc.
9800 Mount Pyramid Court Suite 400
80112, Englewood
+720 437 6500
http://www.ampiopharma.comSector
1st Jan change | Capi. | |
---|---|---|
-86.10% | 325K | |
-1.73% | 105B | |
+3.56% | 97.5B | |
+1.86% | 22.19B | |
-16.58% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-21.20% | 14.52B | |
+5.34% | 14.09B | |
+21.78% | 10.99B |
- Stock Market
- Equities
- AMPE Stock
- Company Ampio Pharmaceuticals, Inc.